Press Releases
Garheng Kong Named to LabCorp Board of Directors
Laboratory Corporation of America® Holdings (LabCorp®) today announced that Garheng Kong MD PhD has been appointed to its Board of Directors effective December 1 2013. “We are delighted that Garheng has accepted our invitation to...
Press Releases
Polyplus-transfection and Merck sign a license and supply agreement for PEI-based transfection reagents
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology and Merck, a leading pharmaceutical, chemical and life science company with total revenues of EUR 11.2 billion in 2012, announce today a global prior use license...
Press Releases
Banook Central Imaging selected by Servier to provide innovative image analysis services based on a combination of RECIST, IrRC and TGR criteria
Banook Central Imaging (Banook CI), a global imaging core lab for drug and device clinical trials, announces today that it has been selected by Servier to assess the potential anti-tumor activity of a novel monoclonal antibody based on the...
Press Releases
6th International Conference on Drug Discovery and Therapy
It is a great pleasure of Eureka Science to announce the latest editions of our very successful series of conferences; the “6th International Conference on Drug Discovery and Therapy” and the “3rd Biotechnology World Congress” in Dubai UAE. This...
Press Releases
SMi present the 13th annual event – Advances and Progress in Drug Design
SPONSORED BY CHEMICAL COMPUTING GROUPSMi are proud to present the 13th annual Advances and Progress in Drug Design conference, convening in Central London on Monday 17 and Tuesday 18 February 2014. This exciting event will focus on new approaches...
Press Releases
Agilent Technologies and Seoul National University Hospital Collaborate on Biomarker Research
Agilent Technologies Inc. and Seoul National University Hospital one of Korea’s top medical centers today announced a strategic collaboration for the development and verification of various biomarkers for the development of drugs including narcotics immune-suppressants and biomarkers. ...
Press Releases
Nosopharm receives EUR 870,000 (USD 1.18 million) to help combat antibiotic resistance
Nosopharm specializes in the research and development of new anti-infective drugs, today announces that it has secured funding of EUR 870,000 (USD 1.18 million). The company is receiving this funding as part of the OOPERA...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















